Sources Wilding JPH, Batterham RL, Calanna S, et al
70,71 Additionally, the exploration of GLP-1R positive allosteric modulators (PAMs) offers a new regulatory approach that could enhance the therapeutic profile of small-molecule GLP-1R agonists
TRIUMPH-4 (445 patients with knee osteoarthritis) reported results in December 2025, showing the 28.7% weight loss figure that made headlines worldwide (Lilly Press Release, Dec 2025)
Semaglutide has been associated with modest increases in heart rate (average 24 beats per minute) in clinical trials
Safety and Side Effects Like all therapeutic interventions, GLP-1 agonists come with their set of side effects
Giving infants vitamin B6 by IV controls seizures caused by a condition called pyridoxine-dependent epilepsy